Filing Details

Accession Number:
0001562180-18-002144
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-02 19:54:35
Reporting Period:
2018-04-30
Accepted Time:
2018-05-02 19:54:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1656328 Sienna Biopharmaceuticals Inc. SNNA Pharmaceutical Preparations (2834) 273364627
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1711463 Todd Harris C/O Sienna Biopharmaceuticals, Inc.
30699 Russell Ranch Road, Suite 140
Westlake Village CA 91362
Head Of Corporate Development No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-04-30 100 $20.00 570,991 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 22, 2017.